$89.95
Price
$51.8B
Market Cap
53.5
P/E Ratio
26.6
Forward P/E
$1.68
EPS (TTM)
—
Dividend Yield
$4.3B
Cash
$705M
Total Debt
576M
Shares Out
$72.30
$96.29
52-Week Range
Institutional Ownership of Edwards Lifesciences Corp
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 165.2K | $15M | — | — |
Trading Activity for Edwards Lifesciences Corp
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| SELL | -3.4% | 165.2K | $15M | $83.20 | |
| 2026-Q1 | |||||
| SELL | -5.5% | 171.0K | $14M | $82.84 | |
| 2025-Q4 | |||||
| SELL | -2.1% | 180.9K | $15M | $83.98 | |
| 2025-Q3 | |||||
| BUY | +3.7% | 184.7K | $14M | $78.16 | |
| SELL | EXIT | — | — | $78.16 | |
| 2025-Q2 | |||||
| SELL | -7.2% | 178.0K | $14M | $75.18 | |
| BUY | NEW | 257 | $19026 | $75.18 | |
| 2025-Q1 | |||||
| SELL | -43.5% | 191.8K | $15M | $71.24 | |
| SELL | EXIT | — | — | $71.24 | |
| 2024-Q4 | |||||
| SELL | -99.9% | 257 | $19026 | $69.89 | |
| SELL | -5.5% | 339.4K | $25M | $69.89 | |
| 2024-Q3 | |||||
| BUY | +0.1% | 446.3K | $29M | $68.26 | |
| BUY | +1.4% | 359.3K | $24M | $68.26 | |
| 2024-Q2 | |||||
| BUY | +0.1% | 446.0K | $41M | $87.86 | |
| BUY | +44.4% | 354.4K | $23M | $87.86 | |
| 2024-Q1 | |||||
| BUY | +1.1% | 445.7K | $43M | $86.09 | |
| SELL | -2.1% | 245.5K | $22M | $86.09 | |
| 2023-Q4 | |||||
| BUY | +0.1% | 440.9K | $34M | $69.18 | |
| BUY | +29.3% | 250.7K | $22M | $69.18 | |
| 2023-Q3 | |||||
| BUY | +0.2% | 440.6K | $31M | $77.97 | |
| SELL | -38.5% | 193.8K | $13M | $77.97 | |
| 2023-Q2 | |||||
| BUY | +3.2% | 439.9K | $41M | $87.41 | |
| SELL | -4.5% | 315.2K | $30M | $87.41 | |
| SELL | EXIT | — | — | $87.41 | |
| 2023-Q1 | |||||
| SELL | -1.1% | 330.1K | $27M | $78.21 | |
| 2022-Q4 | |||||
| SELL | -0.9% | 426.2K | $32M | $75.03 | |
| BUY | +0.6% | 333.8K | $25M | $75.03 | |
| 2022-Q3 | |||||
| BUY | +3.2% | 430.2K | $36M | $97.36 | |
| SELL | -2.7% | 331.6K | $27M | $97.36 | |
| BUY | NEW | 10.0K | $825000 | $97.36 | |
| 2022-Q2 | |||||
| BUY | +2.9% | 416.9K | $40M | $97.39 | |
| SELL | -4.9% | 340.7K | $32M | $97.39 | |
| 2022-Q1 | |||||
| SELL | -0.2% | 405.1K | $48M | $111.42 | |
| BUY | +1.4% | 358.2K | $42M | $111.42 | |
| 2021-Q4 | |||||
| SELL | -25.3% | 353.1K | $46M | $116.59 | |
| BUY | +0.9% | 405.8K | $53M | $116.59 | |
| 2021-Q3 | |||||
| SELL | -2.3% | 472.6K | $54M | $114.70 | |
| SELL | -0.8% | 402.1K | $46M | $114.70 | |
| 2021-Q2 | |||||
| SELL | -5.9% | 483.5K | $50M | $94.88 | |
| BUY | +3.9% | 405.5K | $42M | $94.88 | |
| 2021-Q1 | |||||
| SELL | -13.6% | 513.9K | $43M | $84.64 | |
| BUY | +0.6% | 390.1K | $33M | $84.64 | |
| 2020-Q4 | |||||
| SELL | -5.8% | 595.0K | $54M | $84.00 | |
| BUY | +3.9% | 387.8K | $35M | $84.00 | |
| 2020-Q3 | |||||
| SELL | -5.5% | 631.7K | $50M | $78.41 | |
| BUY | +0.2% | 373.4K | $30M | $78.41 | |
| 2020-Q2 | |||||
| SELL | EXIT | — | — | $71.91 | |
| BUY | +181.8% | 668.5K | $46M | $71.91 | |
| BUY | +214.7% | 372.6K | $26M | $71.91 | |
| 2020-Q1 | |||||
| SELL | -9.0% | 753.6K | $142M | $226.81 | |
| SELL | -36.6% | 237.2K | $45M | $226.81 | |
| SELL | -7.8% | 118.4K | $22M | $226.81 | |
| 2019-Q4 | |||||
| BUY | +28.7% | 828.4K | $193M | $235.15 | |
| SELL | -21.9% | 374.1K | $87M | $235.15 | |
| BUY | +1.0% | 128.5K | $30M | $235.15 | |
| 2019-Q3 | |||||
| BUY | +12.8% | 643.5K | $142M | $215.66 | |
| SELL | -8.0% | 478.8K | $105M | $215.66 | |
| BUY | +0.2% | 127.2K | $28M | $215.66 | |
| 2019-Q2 | |||||
| SELL | -21.3% | 520.3K | $96M | $181.10 | |
| BUY | +24.4% | 570.3K | $105M | $181.10 | |
| BUY | +2.5% | 127.0K | $23M | $181.10 | |
| 2019-Q1 | |||||
| SELL | -19.5% | 660.8K | $126M | $170.96 | |
| BUY | +64.8% | 458.4K | $88M | $170.96 | |
| BUY | +1.4% | 123.9K | $24M | $170.96 | |
| 2018-Q4 | |||||
| BUY | +0.3% | 821.1K | $126M | $150.21 | |
| BUY | +27.7% | 278.2K | $43M | $150.21 | |
| SELL | -32.4% | 122.2K | $19M | $150.21 | |
| 2018-Q3 | |||||
| SELL | -8.1% | 819.0K | $143M | $144.92 | |
| SELL | -10.5% | 217.8K | $38M | $144.92 | |
| BUY | +4.7% | 180.7K | $31M | $144.92 | |
| 2018-Q2 | |||||
| SELL | -21.3% | 891.4K | $130M | $137.95 | |
| BUY | NEW | 243.3K | $35M | $137.95 | |
| BUY | +0.8% | 172.5K | $25M | $137.95 | |
| 2018-Q1 | |||||
| SELL | -15.5% | 1.1M | $158M | $131.83 | |
| BUY | +5.9% | 171.2K | $24M | $131.83 | |
Insider Trading for Edwards Lifesciences Corp
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.